万维提示：

1、投稿方式：在线投稿。

2、刊内网址（202502期）：

https://journals.lww.com/gscm/pages/default.aspx

3、投稿系统：

https://www2.cloud.editorialmanager.com/gscm/default2.aspx

4、刊内电话：010-64089043

5、刊内邮箱：GSCM2023@126.com

6、出刊日期：季刊，逢季末月出版。

7、官方微信公众号：中医规范与标准

8、官网信息：不收版面费审稿费。

2025年7月17日星期四

Instructions For Author

【官网信息】

The

Editorial Office is pleased to answer any questions you may have about

preparing your manuscript in accordance with our guidelines.

Email: GSCM2023@126.com

AIMS AND SCOPE

Guidelines

and Standards in Chinese Medicine (GSCM) is an international open

access journal publishing peer-reviewed papers focusing on guidelines

and standards-related studies of Chinese medicine, herbal medicine,

acupuncture, moxibustion, homeopathy, complementary and integrative

medicine, and others.

We particularly welcome studies including but not limited to:

Development

and application of clinical practice guidelines, experts consensus,

international/ national/ industry/ group/ standards;

Quality

assessment of published clinical practice guidelines, experts

consensus, international/ national/ industry/ group/ standards;

New tools/ methods/ methodological issues related to guidelines, consensus or standards;

We also welcome studies that could promote the development and application of guidelines and standards:

Design

protocol, statistical analysis and reporting of clinical researches

(randomized/ non-randomized controlled trials/ cohorts/ case-control

studies/ case series/ case reports)

Basic

science research using modern technology and method to explore the

mechanism of the disease based on Chinese medicine, complementary and

integrative medicine hypothesis and theory;

Pharmacy

and pharmacology researches with focus on processing, extraction,

identification and others to promote the innovation, modernization and

application of herbal medicine;

Interdisciplinary studies, such as evidence-based public health policy and practice, medical-industrial crossover research.

We

now publish original research and review papers. We may also publish

opinion, perspective, letter to editors or short communications which

are by invitation only.

ONLINE SUBMISSION

All manuscripts must be submitted online at: https://www.editorialmanager.com/GSCM/default2.aspx.

First-time users

Please

click the Register button at

https://www.editorialmanager.com/GSCM/default2.aspx. Upon successful

registration, you will be sent an email providing your username and

password. Save this information for future reference. Note: If you have

received an email from us with an assigned username and password, or if

you are a repeat user, do not register again. Once you have an assigned

username and password, you do not have to re-register.

Authors

Please

click the Login button from the menu at the top of the page and login

to the system as an author. Submit your manuscript according to the

author instructions. You will be able to track the process of your

manuscript through the system.

JOURNAL POLICIES

DUPLICATE PUBLICATION

Manuscripts

are reviewed for possible publication with the understanding that they

are being submitted only to the Guidelines and Standards in Chinese

Medicine and have not been published, simultaneously submitted, or

already accepted for publication elsewhere. The Editorial team may

subject any manuscript submitted for consideration of publication in

Guidelines and Standards in Chinese Medicine to plagiarism-detection

software.

This

does not preclude consideration of a manuscript that has been rejected

by another journal or a complete report that follows publication of

preliminary findings elsewhere, usually in the form of an abstract.

Copies of any possibly duplicate published material should be submitted

with the manuscript under consideration, with a statement in the cover

letter as to why the manuscript currently being submitted is not a

duplicate publication.

DISCLOSURE OF CONFLICTS

Authors

must state all possible conflicts of interest in the manuscript,

including financial, consultant, institutional and other relationships

that might lead to bias or a conflict of interest. If there is no

conflict of interest, this should also be explicitly stated as none

declared. All sources of funding should be acknowledged in the

manuscript.

All

relevant conflicts of interest and sources of funding should be

included on the title page of the manuscript with the heading "Conflicts

of Interest” and “Source of Funding".

For

example: “Conflicts of Interest: A has received honoraria from Company

Z. B is currently receiving a grant (#12345) from Organization Y, and is

on the speaker's bureau for Organization X - the CME organizers for

Company A. For the remaining authors none were declared.”

“Source of Funding”: list all the grant supports/funders for the study.

A

financial disclosure section is part of the submission process and must

be completed by each author at first revision. This information is for

review by the Editors but will be published if relevant to the content

of the accepted manuscript.

The

primary purpose of the disclosure section is to determine whether

authors have received any commercial financial support that could create

a conflict of interest. In addition to monetary interests, a potential

for conflict of interest can exist whether or not an indi­vidual

believes that a relationship (such as dual commitments, competing

interests, or competing loyalties) affects his or her scientific

judgment. Please review ICMJE Uniform Requirements for Manuscripts

Submitted to Biomedical Journals at the following link:

http://www.icmje.org/conflicts-of-interest.

Studies in humans and animals

If

the work involves the use of human subjects, the author should ensure

that the work described has been carried out in accordance with The Code

of Ethics of the World Medical Association (Declaration of Helsinki)

for experiments involving humans. The manuscript should be in line with

the Recommendations for the Conduct, Reporting, Editing and Publication

of Scholarly Work in Medical Journals and aim for the inclusion of

representative human populations (sex, age and ethnicity) as per those

recommendations. The terms sex and gender should be used correctly.

Authors

should include a statement in the manuscript that informed consent was

obtained for experimentation with human subjects. The privacy rights of

human subjects must always be observed.

All

animal experiments should comply with the ARRIVE guidelines and should

be carried out in accordance with the U.K. Animals (Scientific

Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU

for animal experiments, or the National Institutes of Health guide for

the care and use of Laboratory animals (NIH Publications No. 8023,

revised 1978) and the authors should clearly indicate in the manuscript

that such guidelines have been followed. The sex of animals must be

indicated, and where appropriate, the influence (or association) of sex

on the results of the study.

Authors

describing studies involving animals must have consulted the ‘Animal

Research: Reporting In Vivo Experiments’ (ARRIVE) 2.0 guidelines,

developed by the NC3Rs to improve standards of reporting, ensuring that

the data from animal experiments can be fully scrutinized and utilized.

Articles reporting in vivo experiments must adhere to the ARRIVE Essential

10 checklist as a minimum, and we encourage authors to use the full

ARRIVE 2.0 checklist. The relevant information outlined in these

guidelines should be included in the appropriate section of the article.

...

更多详见：

https://journals.lww.com/gscm/Pages/Information-to-Authors.aspx